Last reviewed · How we verify

NCT07127952: GAVE

Correlations of the Microvascular Abnormalities on NVC (Nail Fold Video Capillaroscopy) and GAVE (Gastric Antral Vascular Ectasia) as Seen on EGD

ENROLLING BY INVITATION NA Last updated 29 January 2026
What this trial tests

NA trial testing Video Capillaroscopy in Gastric Antral Vascular Ectasia in 75 participants. Enrolling by invitation.

Timeline
3 May 2025
Primary endpoint
31 December 2026
31 December 2026

Quick facts

Lead sponsorMayo Clinic
PhaseNA
StatusENROLLING BY INVITATION
Study typeINTERVENTIONAL
Allocationnon randomized
Designsingle group
Maskingnone
Primary purposesupportive care
Enrollment75
Start date3 May 2025
Primary completion31 December 2026
Estimated completion31 December 2026
Sites3 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Mayo Clinic

Who can join

Adults 18 to 95, any sex, with Gastric Antral Vascular Ectasia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this research is to determine whether a procedure called capillaroscopy can help distinguish patients who are diagnosed with GAVE (gastric antral vascular ectasia) with an autoimmune disease versus idiopathic/other conditions based on EGD findings.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Gastric Antral Vascular Ectasia

Currently open trials in the same condition.

Other Mayo Clinic trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07127952.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing